Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
47.55
+0.14 (0.30%)
At close: Mar 3, 2025, 4:00 PM
47.90
+0.35 (0.74%)
After-hours: Mar 3, 2025, 6:09 PM EST
Exact Sciences Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Exact Sciences stock have an average target of 71.75, with a low estimate of 60 and a high estimate of 90. The average target predicts an increase of 50.89% from the current stock price of 47.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 10 | 11 | 10 | 10 |
| Buy | 6 | 6 | 6 | 5 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +47.21% | Feb 26, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $70 → $73 | Buy | Maintains | $70 → $73 | +53.52% | Feb 24, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $72 → $65 | Strong Buy | Maintains | $72 → $65 | +36.70% | Feb 20, 2025 |
| Barclays | Barclays | Buy Maintains $70 → $65 | Buy | Maintains | $70 → $65 | +36.70% | Feb 20, 2025 |
| Barclays | Barclays | Buy Initiates $70 | Buy | Initiates | $70 | +47.21% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
3.12B
from 2.76B
Increased by 12.98%
Revenue Next Year
3.50B
from 3.12B
Increased by 12.22%
EPS This Year
-0.49
from -5.59
EPS Next Year
0.36
from -0.49
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.3B | 3.8B | 4.2B | ||
| Avg | 3.1B | 3.5B | 3.7B | ||
| Low | 2.9B | 3.1B | 3.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.3% | 22.1% | 18.8% | ||
| Avg | 13.0% | 12.2% | 6.7% | ||
| Low | 5.2% | 0.4% | -9.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.14 | 0.91 | 2.03 | ||
| Avg | -0.49 | 0.36 | 1.27 | ||
| Low | -2.20 | -0.40 | 0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 468.8% | ||
| Avg | - | - | 257.2% | ||
| Low | - | - | 32.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.